These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Paclitaxel and carboplatin for recurrent salivary gland malignancies. Airoldi M; Fornari G; Pedani F; Marchionatti S; Gabriele P; Succo G; Bumma C Anticancer Res; 2000; 20(5C):3781-3. PubMed ID: 11268454 [TBL] [Abstract][Full Text] [Related]
3. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group. Gilbert J; Li Y; Pinto HA; Jennings T; Kies MS; Silverman P; Forastiere AA Head Neck; 2006 Mar; 28(3):197-204. PubMed ID: 16470745 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330 [TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
7. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
8. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Airoldi M; Pedani F; Succo G; Gabriele AM; Ragona R; Marchionatti S; Bumma C Cancer; 2001 Feb; 91(3):541-7. PubMed ID: 11169936 [TBL] [Abstract][Full Text] [Related]
9. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Chen AM; Garcia J; Bucci MK; Quivey JM; Eisele DW Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):138-43. PubMed ID: 17049183 [TBL] [Abstract][Full Text] [Related]
10. [Carcinoma of salivary glands--a clinical analysis of 342 cases]. Yu GY; Ma DQ Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):395-8. PubMed ID: 3032547 [TBL] [Abstract][Full Text] [Related]
11. Malignant minor salivary gland tumors of the larynx. Ganly I; Patel SG; Coleman M; Ghossein R; Carlson D; Shah JP Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):767-70. PubMed ID: 16847187 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Muggia FM; Blessing JA; Waggoner S; Berek JS; Monk BJ; Sorosky J; Pearl ML Gynecol Oncol; 2005 Jan; 96(1):108-11. PubMed ID: 15589588 [TBL] [Abstract][Full Text] [Related]
13. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280 [TBL] [Abstract][Full Text] [Related]
14. A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma. Kulke MH; Muzikansky A; Clark J; Enzinger PC; Fidias P; Kinsella K; Michelini A; Fuchs CS Cancer Invest; 2006; 24(4):346-50. PubMed ID: 16777685 [TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study. Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N J BUON; 2007; 12(1):33-9. PubMed ID: 17436399 [TBL] [Abstract][Full Text] [Related]
16. [Adenoid cystic carcinoma of the head and neck: a review of 30 cases]. Raux-Rakotomalala F; Houliat T; Martel J; Stoll D; Bébéar JP; Darrouzet V Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):235-41. PubMed ID: 15038566 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer. Burger RA; DiSaia PJ; Roberts JA; O'rourke M; Gershenson DM; Homesley HD; Lichtman SM; Barnes W; Moore DH; Monk BJ Gynecol Oncol; 1999 Feb; 72(2):148-53. PubMed ID: 10021293 [TBL] [Abstract][Full Text] [Related]
18. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL; Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035 [TBL] [Abstract][Full Text] [Related]
19. Malignant tumors of intraoral minor salivary glands. Copelli C; Bianchi B; Ferrari S; Ferri A; Sesenna E Oral Oncol; 2008 Jul; 44(7):658-63. PubMed ID: 17996484 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Chen AM; Bucci MK; Quivey JM; Garcia J; Eisele DW; Fu KK Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1044-50. PubMed ID: 16965870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]